Psychosis and Schizophrenia

schizophrenia is a chronic mental disorder that affects around 1% of the worldwide population. It causes psychotic behaviors, social and emotional disruptions and different cognitive impairments.

The causes of the disease are still not clear but studies show that both genetic and environmental factors have an effect on it.

PPARγ

PPARγ is part of the nuclear receptor family and one of the non-GPCR Cannabinoid receptors. PPARγ is involved in the regulation of fat cells/adipose tissue, insulin sensitivity and inflammation.

GPR18

GPR18 is involved in apoptosis, microglial migration in the CNS and other immune responses.

Insomnia

Insomnia is a sleep disorder characterized by inability to sleep or sleeping less time than desired. The endocannabinoid system plays a role in sleep processes and medical cannabis users already reported benefits of cannabis use to sleep.

Pain

pain is a very good target for therapeutic cannabinoids.

Prostate Cancer

Prostate cancer is the development of cancer in the prostate.

Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for Cannabinoid therapy.

Cervical cancer

Cervical cancer is a type of cancer that develops from the cervix.

Breast cancer

Breast cancers develop from breast tissue. cannabinoids have anti breast cancer properties involving inhibition of cancer growth and metastasis.

Cancer

In spite of the increasing scientific interest to understand how cannabinoids can help to treat cancer disease, symptoms and the associated chemotherapy side effects, the existing scientific evidence is not enough to satisfy the clinical criteria to consider cannabinoids as a part of the treatment.